ECNP Negative Results Prize in Clinical Neuroscience

The ECNP Negative Results Prize in Clinical Neuroscience recognises those who have made exceptional contributions to CNS treatment development by publishing clinical research with negative findings. Winners are selected especially on the basis of the impact of their findings in helping the field to optimise its resource and investment allocation and, in doing so, advance long-term treatment development. 2019 was the first year it has been given.ECNP Award for Negative Results in Clinical Neuroscience

The 2019 winners are:

  • David Brown
  • Kazuyuki Nakagome
  • Joachim Cordes
  • Ronald Brenner
  • Gerhard Gründer
  • Richard S.E. Keefe
  • Robert Riesenberg
  • David P. Walling
  • Kristen Daniels
  • Lara Wang
  • Jennifer McGinniss
  • Michael Sand

‘Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial’. Click here to read the full article on Schizophrenia Bulletin 45.2, March 2019, pp 350-359.